US Market Report for Dialysis Catheters 2017 - MedCore is a new market research publication announced by Reportstack. General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
The dialysis catheter market is composed of short-term (acute) hemodialysis, long-term (chronic) hemodialysis and peritoneal dialysis (PD) catheters. The largest segment in the total dialysis catheter market in 2016 was represented by long-term hemodialysis catheters. Growth in the long-term hemodialysis catheter segment was driven by increases in the conventional long-term hemodialysis and the antimicrobial long-term hemodialysis sub-segments. Moderate growth in the value of the total dialysis catheter market is expected to persist over the forecast period. However, the shift toward fistula use in the U.S. will continue to hinder growth in the value of the total dialysis catheter market. A greater focus on reducing catheter-related bloodstream infections (CRBSIs) has mainly been driven by organizations such as the Institute for Healthcare Improvement (IHI), with its 5 Million Lives Campaign; the Centers for Disease Control (CDC), with their infection control guidelines; and reimbursement changes made by Medicare. Medical facilities have responded positively because infections are a preventable expense and worsen patient outcomes. The effort to reduce catheter-related infections will result in more catheters with infection-reducing properties. Additionally, antimicrobial catheters sell at a premium and will increase the value of the market.
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
The dialysis catheter market is composed of short-term (acute) hemodialysis, long-term (chronic) hemodialysis and peritoneal dialysis (PD) catheters. The largest segment in the total dialysis catheter market in 2016 was represented by long-term hemodialysis catheters. Growth in the long-term hemodialysis catheter segment was driven by increases in the conventional long-term hemodialysis and the antimicrobial long-term hemodialysis sub-segments. Moderate growth in the value of the total dialysis catheter market is expected to persist over the forecast period. However, the shift toward fistula use in the U.S. will continue to hinder growth in the value of the total dialysis catheter market. A greater focus on reducing catheter-related bloodstream infections (CRBSIs) has mainly been driven by organizations such as the Institute for Healthcare Improvement (IHI), with its 5 Million Lives Campaign; the Centers for Disease Control (CDC), with their infection control guidelines; and reimbursement changes made by Medicare. Medical facilities have responded positively because infections are a preventable expense and worsen patient outcomes. The effort to reduce catheter-related infections will result in more catheters with infection-reducing properties. Additionally, antimicrobial catheters sell at a premium and will increase the value of the market.
Complete report available @ US Market Report for Dialysis Catheters 2017 - MedCore
Dialysis catheters are used for facilitating dialysis for patients whose kidneys are unable to properly filter water and waste. Most patients treated with dialysis have been diagnosed with end-stage renal disease (ESRD); however, patients suffering from acute kidney failure can also receive dialysis. Glomerular filtration rate (GFR) is a test used to assess kidney function. In turn, patients with chronically low GFRs are diagnosed with chronic kidney disease (CKD). When the GFR drops below the threshold, which is when kidney activity is less than 10% of normal levels, patients are considered to have progressed to Stage 5 CKD or ESRD. Patients with ESRD require a kidney transplant or dialysis. However, many ESRD patients are not suitable candidates for kidney transplants. In addition, there is a shortage of available organs; in the United States, only 20% of patients on waiting lists for kidney transplants will receive a kidney within the first year. Owing to advancement in dialysis technologies, patients receiving dialysis can survive for decades, barring other health problems. Despite this, patients on dialysis have a high mortality rate due to old age and multiple health conditions.
Scope
2013-2023
2013-2023
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research
###
No comments:
Post a Comment